US guidelines for prostate cancer screening
| American Cancer Society26 | US Preventive Services Task Force27 | National Comprehensive Cancer Network12 |
|---|---|---|
| Men should make an informed decision with their physician about whether to be screened based on an understanding of the uncertainties, risks, and benefits of screening. The discussion about screening should take place at: Age 50 for men at average risk of prostate cancer with a life expectancy of at least 10 years Age 45 for men at high risk of prostate cancer (blacks, men with a first-degree relative diagnosed with prostate cancer before age 65) Age 40 for men at even higher risk (more than one first-degree relative diagnosed with prostate cancer at an early age). | Recommends against screening with prostate-specific antigen testing. | Based on family history, race, and a history of prostate disease and screening, men ages 45 to 75 should have a discussion with their physician about the risks and benefits of prostate cancer screening, including prostate-specific antigen testing and digital rectal examination. |